List of Tables
Table 1. Global Hemoperfusion Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hemoperfusion Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hemoperfusion Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hemoperfusion Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hemoperfusion Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hemoperfusion Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hemoperfusion Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hemoperfusion Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hemoperfusion, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemoperfusion, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemoperfusion, Product Type & Application
Table 12. Global Key Manufacturers of Hemoperfusion, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hemoperfusion Sales by Region (2020-2025) & (K Units)
Table 18. Global Hemoperfusion Sales Market Share by Region (2020-2025)
Table 19. Global Hemoperfusion Sales by Region (2026-2031) & (K Units)
Table 20. Global Hemoperfusion Sales Market Share by Region (2026-2031)
Table 21. Global Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hemoperfusion Revenue Market Share by Region (2020-2025)
Table 23. Global Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hemoperfusion Revenue Market Share by Region (2026-2031)
Table 25. North America Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 27. North America Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 28. North America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hemoperfusion Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hemoperfusion Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hemoperfusion Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hemoperfusion Sales (K Units) by Type (2020-2025)
Table 51. Global Hemoperfusion Sales (K Units) by Type (2026-2031)
Table 52. Global Hemoperfusion Sales Market Share by Type (2020-2025)
Table 53. Global Hemoperfusion Sales Market Share by Type (2026-2031)
Table 54. Global Hemoperfusion Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hemoperfusion Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hemoperfusion Revenue Market Share by Type (2020-2025)
Table 57. Global Hemoperfusion Revenue Market Share by Type (2026-2031)
Table 58. Global Hemoperfusion Price (USD/Unit) by Type (2020-2025)
Table 59. Global Hemoperfusion Price (USD/Unit) by Type (2026-2031)
Table 60. Global Hemoperfusion Sales (K Units) by Application (2020-2025)
Table 61. Global Hemoperfusion Sales (K Units) by Application (2026-2031)
Table 62. Global Hemoperfusion Sales Market Share by Application (2020-2025)
Table 63. Global Hemoperfusion Sales Market Share by Application (2026-2031)
Table 64. Global Hemoperfusion Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hemoperfusion Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hemoperfusion Revenue Market Share by Application (2020-2025)
Table 67. Global Hemoperfusion Revenue Market Share by Application (2026-2031)
Table 68. Global Hemoperfusion Price (USD/Unit) by Application (2020-2025)
Table 69. Global Hemoperfusion Price (USD/Unit) by Application (2026-2031)
Table 70. Jianfan Biotech Company Information
Table 71. Jianfan Biotech Description and Business Overview
Table 72. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Jianfan Biotech Hemoperfusion Product
Table 74. Jianfan Biotech Recent Developments/Updates
Table 75. Kangbei Medical Company Information
Table 76. Kangbei Medical Description and Business Overview
Table 77. Kangbei Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Kangbei Medical Hemoperfusion Product
Table 79. Kangbei Medical Recent Developments/Updates
Table 80. Foshan Boxin (Lily Medical) Company Information
Table 81. Foshan Boxin (Lily Medical) Description and Business Overview
Table 82. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Foshan Boxin (Lily Medical) Hemoperfusion Product
Table 84. Foshan Boxin (Lily Medical) Recent Developments/Updates
Table 85. Baxter Company Information
Table 86. Baxter Description and Business Overview
Table 87. Baxter Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Baxter Hemoperfusion Product
Table 89. Baxter Recent Developments/Updates
Table 90. Asahi Kasei Company Information
Table 91. Asahi Kasei Description and Business Overview
Table 92. Asahi Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Asahi Kasei Hemoperfusion Product
Table 94. Asahi Kasei Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Hemoperfusion Distributors List
Table 98. Hemoperfusion Customers List
Table 99. Hemoperfusion Market Trends
Table 100. Hemoperfusion Market Drivers
Table 101. Hemoperfusion Market Challenges
Table 102. Hemoperfusion Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemoperfusion
Figure 2. Global Hemoperfusion Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hemoperfusion Market Share by Type: 2024 & 2031
Figure 4. Activated Carbon Adsorption Product Picture
Figure 5. Resin Adsorption Product Picture
Figure 6. Global Hemoperfusion Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hemoperfusion Market Share by Application: 2024 & 2031
Figure 8. Hepatic Encephalopathy
Figure 9. Certain Autoimmune Diseases
Figure 10. Drug Overdose
Figure 11. Specific Intoxications
Figure 12. Others
Figure 13. Global Hemoperfusion Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hemoperfusion Market Size (2020-2031) & (US$ Million)
Figure 15. Global Hemoperfusion Sales (2020-2031) & (K Units)
Figure 16. Global Hemoperfusion Average Price (USD/Unit) & (2020-2031)
Figure 17. Hemoperfusion Report Years Considered
Figure 18. Hemoperfusion Sales Share by Manufacturers in 2024
Figure 19. Global Hemoperfusion Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Hemoperfusion Players: Market Share by Revenue in Hemoperfusion in 2024
Figure 21. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 24. North America Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 28. Europe Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 29. Germany Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Hemoperfusion Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Hemoperfusion Revenue Market Share by Region (2020-2031)
Figure 36. China Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 46. Latin America Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Hemoperfusion by Type (2020-2031)
Figure 56. Global Revenue Market Share of Hemoperfusion by Type (2020-2031)
Figure 57. Global Hemoperfusion Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Hemoperfusion by Application (2020-2031)
Figure 59. Global Revenue Market Share of Hemoperfusion by Application (2020-2031)
Figure 60. Global Hemoperfusion Price (USD/Unit) by Application (2020-2031)
Figure 61. Hemoperfusion Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed